Other researchers also found that exendin-4 significantly attenuated the production of inflammatory cytokines (IL-6 and TNF-α) induced by advanced glycation end products in RMCs, which play a major role in the progression of DKD (22). Here, IL6 is linked to diabetic kidney disease.